Subsequent WES on osteosarcoma-susceptible dogs indicated that osteosarcoma may originate from SETD2 mutations, which function as oncogenic drivers (Behjati et al., 2017; Sakthikumar et al., 2018). The gene discussed is SETD2; the disease is osteosarcoma.